Tan Desai, Director-General of the World Health Organization.
The World Health Organization announced on Wednesday a major international trial of three drugs to see if they can improve the condition of hospitalized Covid-19 patients.
Artesunate, imatinib and infliximab will be tested on patients in more than 600 hospitals in 52 countries.
WHO Director-General Tedros Adhanom Ghebreyesus said: “Finding more effective and accessible treatments for Covid-19 patients remains a key need.”
Artesunate is a drug used to treat severe malaria; Imatinib is a drug used to treat certain cancers, and infliximab is a drug used to treat immune system diseases such as Crohn’s disease and rheumatoid arthritis. drug.
They were donated by the manufacturer for testing and have been shipped to relevant hospitals.
“We already have many tools to prevent, test, and treat Covid-19, including oxygen, dexamethasone, and IL-6 blockers. But for patients at all ends of the clinical spectrum, from mild to severe, we need more Multi-tools,” Tedros said in a press conference.
We want to hear your opinion on the news. Subscribe to news 24 Be part of the dialogue in the comments section of this article.
We live in a world where facts and fiction are blurred
In uncertain times, you need news that you can trust.Just for R75 per month, You can access a world of in-depth analysis, investigative news, popular opinions, and a range of features. Journalism strengthens democracy. Invest in the future today.
